# Exela Pharma Sciences LLC - Inspection Records Source: https://www.keypedia.com/companies/exela-pharma-sciences-llc/4e6f3b32-adeb-41f4-b9dd-a8e7784569b3 > Inspection records and compliance data for Exela Pharma Sciences LLC in Lenoir, North Carolina. Access full analysis and detailed observations. --- ## Details - Name: Exela Pharma Sciences LLC - FEI Number: 3008563008 - City: Lenoir - State: North Carolina - Country Name: United States - Address Line 1: 1245 Blowing Rock Blvd - Zip Code: 28645 - Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/73b962be-d31b-4dda-9a43-684980099547) — source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/60077e2a-4655-4ff7-84ff-713e02f8a6b0) — source: FDA, date: November 15, 2024 - [WARNING_LETTER - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/warning_letter/exela-pharma-sciences-llc/832d5d8c-294f-4c3e-9653-35170b74e857) — source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/7fa0eb4d-d50b-495c-9096-18866220d8af) — source: FDA, date: November 15, 2024 - [FDA Inspection 1256957 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/75c7f1e7-b82d-4fec-b497-f6c7b6c3fab8) — source: FDA, date: November 15, 2024 - [FDA Inspection 1256957 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/c49bbdca-1ca9-482e-af5f-49658d2feb1c) — classification: Official Action Indicated (OAI), source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-04](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/5de8eeaa-193a-42b9-94b5-06662a319921) — source: FDA, date: November 4, 2024 - [EIR - Exela Pharma Sciences LLC - 2019-10-22](https://www.keypedia.com/records/eir/exela-pharma-sciences-llc/1ff0bf60-f6da-4f02-ac0b-9fa76949550e) — source: FDA, date: October 22, 2019 - [EIR - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/eir/exela-pharma-sciences-llc/fde33740-f408-45e3-b239-f89a94247474) — source: FDA, date: July 18, 2019 - [WARNING_LETTER - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/warning_letter/exela-pharma-sciences-llc/7cf4c257-966b-464d-879f-fd23e25eae1c) — source: FDA, date: July 18, 2019 - [483 - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/984bf368-0442-4212-a91a-700be16d89e9) — source: FDA, date: July 18, 2019 - [FDA Inspection 1096634 - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/158d466d-f3a8-44b8-83e0-cf8497d372f6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2019 - [483 - Exela Pharma Sciences LLC - 2019-03-29](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/d9a4c4a7-1eb9-418c-958b-e0105fc4cc09) — source: FDA, date: March 29, 2019 - [FDA Inspection 1081405 - Exela Pharma Sciences LLC - 2018-12-19](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/b1e440fb-dc27-4b47-b6cb-b767a36b64d9) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2018 - [FDA Inspection 1067755 - Exela Pharma Sciences LLC - 2018-09-11](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/04fb85de-d9ad-4cdf-b407-5e409c65b64c) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2018 - [FDA Inspection 1026858 - Exela Pharma Sciences LLC - 2017-09-28](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/b2f6d327-c123-48d0-9650-b494e5151266) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2017 - [FDA Inspection 988490 - Exela Pharma Sciences LLC - 2016-06-08](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/2da7002e-f05d-43fa-a427-a0117c3e2ca4) — classification: No Action Indicated (NAI), source: FDA, date: June 8, 2016 - [FDA Inspection 906470 - Exela Pharma Sciences LLC - 2014-11-21](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/3cff58d4-a972-40e4-b2c8-8d44a67b2e1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2014 - [FDA Inspection 893626 - Exela Pharma Sciences LLC - 2014-08-28](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/af7923fe-a410-40ce-bb1b-025b2d211ad0) — classification: No Action Indicated (NAI), source: FDA, date: August 28, 2014 - [FDA Inspection 849770 - Exela Pharma Sciences LLC - 2013-04-12](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/7f2bce59-2fd8-4458-9d73-a50ecc686466) — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2013 ## Related Companies - [Celltrion Inc.](https://www.keypedia.com/companies/celltrion-inc/d3991ec8-423b-4554-9d67-72bc27a8658b) - [Biotest AG](https://www.keypedia.com/companies/biotest-ag/a9ea8ef4-79ad-47e6-a0a9-c434d0a69869) - [IDT Biologika GmbH](https://www.keypedia.com/companies/idt-biologika-gmbh/ec3af185-e1cd-4ce4-9268-6cbfb25fa986) - [SUNNY PHARMTECH INC.](https://www.keypedia.com/companies/sunny-pharmtech-inc/ef1ee573-efce-4b46-a67b-b9dfafc78f82) - [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f) - [Juno Therapeutics, Inc.](https://www.keypedia.com/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35) - [Bavarian Nordic Berna GmbH](https://www.keypedia.com/companies/bavarian-nordic-berna-gmbh/c041bdf1-c3d5-46c3-a216-02ad314f45e0) - [Steriscience Specialties Private Limited](https://www.keypedia.com/companies/steriscience-specialties-private-limited/975a3188-8291-4516-ab80-57e5e3fed081) - [Amneal Oncology Private Limited](https://www.keypedia.com/companies/amneal-oncology-private-limited/f2a5c5fe-c103-4cda-9a5b-c7007f51b4f2) - [Henogen SRL](https://www.keypedia.com/companies/henogen-srl/273669c2-3349-41d3-a904-a56d90f76482) ## Related Officers - [ Drug Investigator](https://www.keypedia.com/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783) - [Joan Cantellops](https://www.keypedia.com/people/joan-cantellops/fc262236-5a32-40d8-bc37-3e8505badbaa) - [Joan M. Cantellops Figueroa](https://www.keypedia.com/people/joan-m-cantellops-figueroa/f791fcd2-a5d4-41e8-a8f2-96569096b422) - [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f) - [Consumer Safety Officer](https://www.keypedia.com/people/brett-weed/6f999684-d103-423a-ba03-6c70821c53b5)